NanoJet technology originated from micro/nano spray research conducted at the University of Strathclyde in the early 2010s. This research innovated nozzle design and droplet dynamics concepts and was practically applied in the EU FP7 CounterFog project (2014–2017). It developed an advanced nano-scale water mist system capable of rapidly removing chemical, biological, and radioactive particulate pollutants from the air. The research team received the European Commission's (EC) Safety Innovation Award in 2022, the only EU project to receive this honor. Peer-reviewed research demonstrated that 2–20 micrometer nano-water mist droplets can effectively capture and neutralize airborne spores, chemical particles, and pathogens, achieving a removal efficiency of 91–98% within 30 seconds. These achievements laid the scientific and technological foundation for the establishment of Innova NanoJet Technologies Ltd., and successfully transformed academic research into commercial products.
CDa Pro is the world's first product to utilize nano-water mist technology for active air disinfection, overcoming the performance limitations of traditional large-droplet sprayers and filter-based air purifiers. CDa Pro generates ultrafine water droplets that collide with and encapsulate viruses, bacteria, allergens, and pollutants in the air, causing them to settle rapidly. The peer-reviewed paper, *Fast Response CBRN High-Scale Decontamination System: CounterFog* (2017), experimentally demonstrated that nano-water mist can remove 91–98% of Bacillus subtilis spores within seconds, scientifically proving the effectiveness of nano-water mist in air purification and pathogen removal.
To further meet the requirements of the medical device market, Innova NanoJet collaborates with several internationally renowned laboratories to conduct product validation:
LMS Technologies is a renowned independent testing laboratory in the United States, ISO/IEC 17025 certified, specializing in air filtration, aerosol science, and microbiological testing. LMS enjoys a high reputation in North America, conducting product safety and filtration performance testing for numerous leading medical and consumer electronics brands. Testing of the NanoJet CDA using MS2 bacteriophage (a human virus mimic) demonstrated a 98.2% removal rate of airborne viruses within 60 minutes.
The NHS (National Health Service) is the UK's public healthcare system, renowned for its high standards of medical services and research capabilities. At the NHS Health Innovation laboratory, NanoJet CDA achieved a 90% removal rate of Micrococcus luteus bacteria using only water in its testing.
NanoJet CDA is built upon over a decade of rigorous scientific research and EU-award-winning innovative technology, and has been validated by two internationally renowned, ISO-certified, and highly credible laboratories: LMS Technologies (USA) and NHS Health Innovation (UK). Experimental results demonstrate its ability to rapidly (within minutes) and safely (using only water) remove viruses and bacteria from the air. The company is currently conducting ongoing clinical trials and scientific research, laying a solid foundation for its entry into the medical device market.
To verify the authenticity and scientific validity of this technology, we conducted multiple measurements with third-party laboratories and professional testing equipment:
These test results scientifically demonstrate that CDa Pro can stably and accurately generate nano-level water mist, which is the core reason why it can quickly capture and remove nano-level viruses and pollutants in the air.
Nozzle Fault Detection and Safety Mechanism
Potential performance degradation: Nozzle performance is primarily affected by the use of substandard water quality, such as water containing lime or other particulate impurities. These impurities can cause nozzle or system blockage, leading to reduced water flow or noticeable water droplet buildup on the machine surface. This is easily noticeable to the user as an early warning sign of performance degradation.
NanoJet CDa Pro factory officially commenced operations and began production on July 11, 2024. Since it has only been on the market for a little over a year, long-term user experience and performance data are still relatively limited. However, since the product's launch, we have actively maintained contact with customers worldwide, collecting user feedback and practical application reports to build a more comprehensive database.
Existing usage reports and data
https://www.climatecontrolnews.com.au/ventilation/hospital-adopts-pro-air
Ongoing international projects
Copyright © 2025 Konda Asia Development Limited — All rights reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, you agree that your information will be combined with that of other users.